REVIEW Report on CHARP (1990-2012)


On April 26, 1986, the fourth reactor of the Chernobyl nuclear power plant in Ukraine in the former Soviet Union exploded. This accident contaminated an area of 10,000 km2 in Ukraine, Belarus and Russia with radioactive materials and affected 4.1 million residents. In 1990, the International Federation of Red Cross and Red Crescent Societies (IFRC) and Red Cross Societies of Ukraine, Belarus and Russia launched the Chernobyl Humanitarian Assistance and Rehabilitation Programme (CHARP) which provided assistance for the affected people until 2012.

In order to contribute to building the IFRC’s preparedness and capacity to respond to nuclear and radiological disasters, the IFRC assessed and analyzed 22 years of experiences by the CHARP and documented as a report.

Activities by the Red Cross and Red Crescent Movement and CHARP are chronologically organized alongside world events and efforts by related international organizations from the occurrence of the Chernobyl accident in 1986 until 2015. Please click here.

You can download the entire report from the following link:

REVIEW Chernobyl Humanitarian Assistance and Rehabilitation Programme (CHARP), 1990-2012 [PDF]

Report files by chapter:

Executive summary [PDF]
A summary of the report including the purpose and overview of the programme, issues in the implementation, conclusions and recommendations.

1. Introduction [PDF]
This section includes the background for the CHARP review, the purpose and objectives, and methodology.

2. Historical overview [PDF]
This chapter explains the historical overview from 1986 when the Chernobyl accident occurred to 2015 when the CHARP review was conducted, including the status of the disaster and the CHARP activities. The roughly 30-year period following the accident was divided into the following descriptive phases:

  • Emergency response and recovery, 1986-1989;
  • Addressing emerging needs, 1990-2000;
  • Socio-economic rehabilitation, 2001-2012; and
  • The situation in 2015.

3. CHARP components [PDF]
This chapter describes the following CHARP activities: (1) radioactive contamination monitoring; (2) medical screening; (3) psychosocial support; (4) distributions of multivitamins, milk powder and medicines; and (5) distributions of information materials.

4. Programme implementation: key issues [PDF]
This chapter summarizes issues that emerged during the CHARP review. The issues are presented from the following viewpoints: initial needs assessment; formulating programme objectives; delivery strategy; management structure; interaction with the UN and scientific community; interaction with public health authorities; and exit strategy. Recommendations for each viewpoint are also stated.

5. Review conclusions [PDF]
This chapter discusses the effectiveness, impact and sustainability of the CHARP activities, and recommendations are presented based on these findings.

6. Final Remarks [PDF]
This chapter includes the review team’s final remarks regarding the CHARP review.

Annex 1: Terms of reference [PDF]
This annex compiles the terms of reference for the CHARP review.

Annex 2: List of people interviewed [PDF]
This annex lists people interviewed during the review.

Annex 3: List of documents reviewed [PDF]
This annex lists more than 180 documents that the review team examined during the review.

Annex 4: Field visits itinerary [PDF]
This annex presents the review team’s itinerary for their field visits to Ukraine, Belarus and Russia.

Annex 5: CHARP timeline, 1986-2015 [PDF]
This annex shows the timeline from the occurrence of the Chernobyl accident in 1986 until 2015, in which activities of the Red Cross and Red Cross Movement and CHARP are organized alongside world events and efforts by related international organizations.

Annex 6: CHARP funding, 1990-2015 [PDF]
This annex describes the funding for CHARP from 1990 to 2015.

Annex 7: CHARP data [PDF]
This annex shows the data analysis results of CHARP activities.

Annex 8: Mobile diagnostic laboratories: operational details [PDF]
This annex elaborates on the operations of the Mobile Diagnostic Laboratories (MDL).